^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Testicular Seminoma |
| Regimen: | TI-CE (carboplatin + etoposide IV + ifosfamide + paclitaxel) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Chemotherapy regimens in metastatic seminoma and non-seminoma: TI-CE…paclitaxel + ifosfamide-carboplatin + etoposide…two cycles TI before stem cell harvesting, therafter three cycles CE as high-dose treatment.
